SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

IDEXX Laboratories, Inc. – ‘10-K’ for 12/31/23 – ‘EX-97.1’

On:  Thursday, 2/22/24, at 4:17pm ET   ·   For:  12/31/23   ·   Accession #:  874716-24-57   ·   File #:  0-19271

Previous ‘10-K’:  ‘10-K’ on 2/16/23 for 12/31/22   ·   Latest ‘10-K’:  This Filing   ·   30 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/22/24  IDEXX Laboratories, Inc.          10-K       12/31/23  140:15M

Annual Report   —   Form 10-K   —   SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   2.96M 
 2: EX-10.28    Material Contract                                   HTML     45K 
 3: EX-10.50    Material Contract                                   HTML     79K 
 4: EX-21       Subsidiaries List                                   HTML     48K 
 5: EX-23       Consent of Expert or Counsel                        HTML     37K 
10: EX-97.1     Clawback Policy re: Recovery of Erroneously         HTML     64K 
                Awarded Compensation                                             
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     42K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     42K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     38K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     38K 
16: R1          Cover Page                                          HTML    103K 
17: R2          Audit Information                                   HTML     42K 
18: R3          Consolidated Balance Sheets                         HTML    167K 
19: R4          Consolidated Balance Sheets (Parenthetical)         HTML     53K 
20: R5          Consolidated Statements of Income                   HTML    138K 
21: R6          Consolidated Statements of Comprehensive Income     HTML     95K 
22: R7          Consolidated Statements of Comprehensive Income     HTML     56K 
                (Parenthetical)                                                  
23: R8          Consolidated Statements of Stockholders? Equity     HTML    101K 
24: R9          Consolidated Statements of Stockholders? Equity     HTML     39K 
                (Parenthetical)                                                  
25: R10         Consolidated Statements of Cash Flows               HTML    126K 
26: R11         Nature of Business, Basis of Presentation and       HTML     43K 
                Principles of Consolidation                                      
27: R12         Summary of Significant Accounting Policies          HTML     64K 
28: R13         Revenue                                             HTML    140K 
29: R14         Acquisitions, Asset Purchases and Investments       HTML     54K 
30: R15         Share-Based Compensation                            HTML    108K 
31: R16         Credit Losses                                       HTML     44K 
32: R17         Inventories                                         HTML     47K 
33: R18         Leases                                              HTML     58K 
34: R19         Property and Equipment, Net                         HTML     72K 
35: R20         Other Current and Long-Term Assets                  HTML     60K 
36: R21         Goodwill and Intangible Assets, Net                 HTML    107K 
37: R22         Accounts Payable, Accrued Liabilities and Other     HTML     63K 
                Long-Term Liabilities                                            
38: R23         Debt                                                HTML     91K 
39: R24         Income Taxes                                        HTML    147K 
40: R25         Earnings Per Share                                  HTML     57K 
41: R26         Commitments, Contingencies and Guarantees           HTML     45K 
42: R27         Segment Reporting                                   HTML    129K 
43: R28         Fair Value Measurements                             HTML    111K 
44: R29         Hedging Instruments                                 HTML     99K 
45: R30         Repurchases of Common Stock                         HTML     62K 
46: R31         Accumulated Other Comprehensive Income              HTML    101K 
47: R32         Preferred Stock                                     HTML     39K 
48: R33         Idexx Retirement and Incentive Savings Plan         HTML     50K 
49: R34         Pay vs Performance Disclosure                       HTML     49K 
50: R35         Insider Trading Arrangements                        HTML     43K 
51: R36         Summary of Significant Accounting Policies          HTML    169K 
                (Policies)                                                       
52: R37         Revenue (Tables)                                    HTML    103K 
53: R38         Share-Based Compensation (Tables)                   HTML     99K 
54: R39         Inventories (Tables)                                HTML     46K 
55: R40         Leases (Tables)                                     HTML     56K 
56: R41         Property and Equipment, Net (Tables)                HTML     73K 
57: R42         Other Current and Long-Term Assets (Tables)         HTML     61K 
58: R43         Goodwill and Intangible Assets, Net (Tables)        HTML    109K 
59: R44         Accounts Payable, Accrued Liabilities and Other     HTML     66K 
                Long-Term Liabilities (Tables)                                   
60: R45         Debt (Tables)                                       HTML     72K 
61: R46         Income Taxes (Tables)                               HTML    148K 
62: R47         Earnings Per Share (Tables)                         HTML     57K 
63: R48         Segment Reporting (Tables)                          HTML    126K 
64: R49         Fair Value Measurements (Tables)                    HTML    104K 
65: R50         Hedging Instruments (Tables)                        HTML     87K 
66: R51         Repurchases of Common Stock (Tables)                HTML     60K 
67: R52         Accumulated Other Comprehensive Income (Tables)     HTML    103K 
68: R53         Idexx Retirement and Incentive Savings Plan         HTML     44K 
                (Tables)                                                         
69: R54         Summary of Significant Accounting Policies          HTML     49K 
                (Details)                                                        
70: R55         Revenue (Revenue Recognition) (Details)             HTML     42K 
71: R56         Revenue (Disaggregation of Revenue by Major         HTML     73K 
                Product and Service Categories) (Details)                        
72: R57         Revenue (Disaggregation of Revenue by Principal     HTML     83K 
                Geographic Area, Based on Customers' Domiciles)                  
                (Details)                                                        
73: R58         Revenue (Product and Service Terms) (Details)       HTML     48K 
74: R59         Revenue (Free or Discounted Instruments and         HTML     43K 
                Systems) (Details)                                               
75: R60         Revenue (Up-Front Consideration Paid to Customers)  HTML     42K 
                (Details)                                                        
76: R61         Revenue (Rebate Arrangements) (Details)             HTML     47K 
77: R62         Revenue (Remaining Performance Obligation)          HTML     81K 
                (Details)                                                        
78: R63         Revenue (Instrument Rental Arrangements) (Details)  HTML     39K 
79: R64         Revenue (Reagent Rental Arrangements) (Details)     HTML     50K 
80: R65         Revenue (Deferred Extended Warranties and           HTML     45K 
                Post-Contract Support Revenue) (Details)                         
81: R66         Revenue (Costs to Obtain a Contract) (Details)      HTML     47K 
82: R67         Acquisitions, Asset Purchases and Investments       HTML    177K 
                (Details)                                                        
83: R68         Share-Based Compensation (Narrative) (Details)      HTML    121K 
84: R69         Share-Based Compensation (Schedule of Selected      HTML     60K 
                Financial Impact of Share-Based Compensation)                    
                (Details)                                                        
85: R70         Share-Based Compensation (Schedule of Weighted      HTML     46K 
                Averages of the Assumptions Used In Estimating the               
                Fair Value of Stock Option Awards) (Details)                     
86: R71         Share-Based Compensation (Schedule of Stock Option  HTML     91K 
                Activity) (Details)                                              
87: R72         Share-Based Compensation (Schedule Of Restricted    HTML     57K 
                Stock Unit Activity) (Details)                                   
88: R73         Credit Losses (Details)                             HTML     51K 
89: R74         Inventories (Narrative) (Details)                   HTML     44K 
90: R75         Inventories (Schedule of Components of              HTML     46K 
                Inventories) (Details)                                           
91: R76         Leases (Narrative) (Details)                        HTML     44K 
92: R77         Leases (Maturities of Operating Lease Liabilities)  HTML     61K 
                (Details)                                                        
93: R78         Leases (Supplemental Cash Flow Information)         HTML     41K 
                (Details)                                                        
94: R79         Property and Equipment, Net (Schedule of Estimated  HTML     52K 
                Useful Lives) (Details)                                          
95: R80         Property and Equipment, Net (Schedule of Property   HTML     60K 
                and Equipment) (Details)                                         
96: R81         Property and Equipment, Net (Summary Of             HTML     51K 
                Depreciation And Amortization, Capitalized                       
                Computer Software For Internal Use And Unpaid                    
                Property Equipment Reflected In Account Payable                  
                And Accrued Expenses) (Details)                                  
97: R82         Property and Equipment, Net (Narrative) (Details)   HTML     39K 
98: R83         Other Current and Long-Term Assets (Schedule of     HTML     50K 
                Other Current Assets) (Details)                                  
99: R84         Other Current and Long-Term Assets (Schedule Of     HTML     51K 
                Other Long-term Assets) (Details)                                
100: R85         Goodwill and Intangible Assets, Net (Narrative)     HTML     45K  
                (Details)                                                        
101: R86         Goodwill and Intangible Assets, Net (Schedule of    HTML     58K  
                Goodwill) (Details)                                              
102: R87         Goodwill and Intangible Assets, Net (Schedule of    HTML     49K  
                Estimated Useful Lives For Intangible Assets)                    
                (Details)                                                        
103: R88         Goodwill and Intangible Assets, Net (Schedule of    HTML     53K  
                Intangible Assets Other Than Goodwill) (Details)                 
104: R89         Goodwill and Intangible Assets, Net (Schedule of    HTML     52K  
                Expected Amortization Expense) (Details)                         
105: R90         Accounts Payable, Accrued Liabilities and Other     HTML     48K  
                Long-Term Liabilities (Schedule of Supplier                      
                Financing Program) (Details)                                     
106: R91         Accounts Payable, Accrued Liabilities and Other     HTML     52K  
                Long-Term Liabilities (Schedule of Accrued                       
                Liabilities) (Details)                                           
107: R92         Accounts Payable, Accrued Liabilities and Other     HTML     43K  
                Long-Term Liabilities (Schedule Of Other Long-term               
                Liabilities) (Details)                                           
108: R93         Debt (Narrative) (Details)                          HTML    201K  
109: R94         Debt (Schedule of Current Senior Notes              HTML     78K  
                Outstanding) (Details)                                           
110: R95         Debt (Schedule of Future Maturities of Long-Term    HTML     57K  
                Debt) (Details)                                                  
111: R96         Income Taxes (Schedule of Earnings Before Income    HTML     46K  
                Taxes) (Details)                                                 
112: R97         Income Taxes (Schedule of Components of Provision   HTML     65K  
                (Benefit) for Income Taxes) (Details)                            
113: R98         Income Taxes (Schedule of Effective Income Tax      HTML     57K  
                Rate Reconciliation) (Details)                                   
114: R99         Income Taxes (Narrative) (Details)                  HTML     53K  
115: R100        Income Taxes (Schedule of Components of Net         HTML     91K  
                Deferred Tax Assets and Liabilities) (Details)                   
116: R101        Income Taxes (Schedule of Valuation Allowance For   HTML     45K  
                Deferred Tax Assets) (Details)                                   
117: R102        Income Taxes (Schedule of Changes in Unrecognized   HTML     49K  
                Tax Benefits) (Details)                                          
118: R103        Earnings Per Share (Schedule of Reconciliation of   HTML     47K  
                Shares Outstanding for Basic and Diluted Earnings                
                Per Share) (Details)                                             
119: R104        Earnings Per Share (Schedule of Number of           HTML     44K  
                Anti-Dilutive Stock Options and Awards) (Details)                
120: R105        Commitments, Contingencies and Guarantees           HTML     48K  
                (Details)                                                        
121: R106        Segment Reporting (Narrative) (Details)             HTML     38K  
122: R107        Segment Reporting (Summary of Segment Performance)  HTML     99K  
                (Details)                                                        
123: R108        Segment Reporting (Schedule of Net Long-Lived       HTML     71K  
                Assets by Principal Geographic Areas) (Details)                  
124: R109        Fair Value Measurements (Narrative) (Details)       HTML     55K  
125: R110        Fair Value Measurements (Schedule of Assets and     HTML    112K  
                Liabilities) (Details)                                           
126: R111        Fair Value Measurements (Schedule of Contingent     HTML     47K  
                Consideration Liability) (Details)                               
127: R112        Hedging Instruments (Narrative) (Details)           HTML    108K  
128: R113        Hedging Instruments (Derivatives Designated in      HTML     57K  
                Cash Flow Hedging Relationships) (Details)                       
129: R114        Hedging Instruments (Schedule of Fair Values and    HTML     76K  
                Balance Sheet Classifications of Derivatives                     
                Designated as Hedging Instruments) (Details)                     
130: R115        Repurchases of Common Stock (Details)               HTML     59K  
131: R116        Accumulated Other Comprehensive Income (Schedule    HTML     87K  
                of AOCI) (Details)                                               
132: R117        Accumulated Other Comprehensive Income (Schedule    HTML     77K  
                of Reclassifications out of AOCI) (Details)                      
133: R118        Preferred Stock (Details)                           HTML     44K  
134: R119        Idexx Retirement and Incentive Savings Plan         HTML     55K  
                (Narrative) (Details)                                            
135: R120        Idexx Retirement and Incentive Savings Plan         HTML     52K  
                (Schedule of Future Benefits Expected to be Paid)                
                (Details)                                                        
137: XML         IDEA XML File -- Filing Summary                      XML    268K  
140: XML         XBRL Instance -- idxx-20231231_htm                   XML   3.62M  
136: EXCEL       IDEA Workbook of Financial Report Info              XLSX    295K  
12: EX-101.CAL  XBRL Calculations -- idxx-20231231_cal               XML    310K 
13: EX-101.DEF  XBRL Definitions -- idxx-20231231_def                XML    973K 
14: EX-101.LAB  XBRL Labels -- idxx-20231231_lab                     XML   2.86M 
15: EX-101.PRE  XBRL Presentations -- idxx-20231231_pre              XML   1.76M 
11: EX-101.SCH  XBRL Schema -- idxx-20231231                         XSD    275K 
138: JSON        XBRL Instance as JSON Data -- MetaLinks              789±  1.18M  
139: ZIP         XBRL Zipped Folder -- 0000874716-24-000057-xbrl      Zip    754K  


‘EX-97.1’   —   Clawback Policy re: Recovery of Erroneously Awarded Compensation


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C: 
  Document  

Exhibit 97.1

IDEXX LABORATORIES, INC.
AMENDED & RESTATED CLAWBACK POLICY
Adopted by the Board: October 18, 2023

1.Purpose. The Board believes that it is in the best interests of the Company and its shareholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has, therefore, adopted this Policy, which provides for the recoupment of certain executive compensation in the event of an Accounting Restatement and is designed to comply with, and will be interpreted to be consistent with, the Applicable Rules.

2.Definitions.

a.“Accounting Restatement” means a “Big R” Restatement or a “little R” Restatement.

b.“Accounting Restatement Date” means the earlier to occur of (i) the date on which the Board, or the officers of the Company authorized to take action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare an Accounting Restatement and (ii) the date on which any court, regulator, or other legally authorized body directs the Company to prepare an Accounting Restatement, in either case, regardless of whether or when the restated financial statements are filed with the SEC.

c.“Additional Compensation” means (i) the portion of an annual bonus, if any, that is not based upon the attainment of a Financial Reporting Measure and (ii) equity compensation awards that do not contain vesting terms based on the attainment of a Financial Reporting Measure.

d.“Applicable Rules” means Section 10D of the Exchange Act, Rule 10D-1 promulgated under the Exchange Act, and Nasdaq Listing Rule 5608, in each case, as amended from time to time.

e.“Big R” Restatement” means an accounting restatement by the Company due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required restatement to correct an error in the Company’s previously issued financial statements that is material to the previously issued financial statements (i.e., a “Big R” restatement).

f.“Board” means the Board of Directors of the Company.

g.“Clawback Period” means the three completed fiscal years immediately preceding the Accounting Restatement Date as well as any transition period that results from a change in the Company’s fiscal year within or immediately following those three completed fiscal years; provided, that a transition period lasting nine months or longer will count as a completed fiscal year for purposes determining the Clawback Period.

h.“Code” means the Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

i.“Committee” means the Compensation and Talent Committee of the Board.

j.“Company” means IDEXX Laboratories, Inc., a Delaware corporation.

k.“Company Group” means the Company and each of its direct and indirect subsidiaries.




l.“Covered Executives” means the Company’s president, principal financial officer, and principal accounting officer (or, if there is no such accounting officer, the controller), any vice-president of the Company in charge of a principal business unit, division, or function (such as sales, administration, or finance), any other officer of the Company who performs a policy-making function, and any other person who performs similar policy-making functions for the Company. An executive officer of the Company’s parent(s) or subsidiaries is deemed to be a Covered Executive if the executive officer performs policy-making functions for the Company. For purposes of this definition, policy-making functions are not intended to include policy-making functions that are not significant, and identification of a Covered Executive for purposes of this definition would include, at a minimum, executive officers identified pursuant to Item 401(b) of Regulation S-K.

m.“Effective Date” means October 2, 2023.

n.“Erroneously Awarded Compensation” means, in the event of an Accounting Restatement, the amount of Incentive-Based Compensation Received by a Covered Executive that exceeds the amount of Incentive-Based Compensation that otherwise would have been Received by such Covered Executive had it been determined based on the restated amounts in such Accounting Restatement, as determined in the sole discretion of the Board based on all applicable facts and circumstances (including, without limitation, the time value of money, the gross amount of dividends or other distributions received by the Covered Executive in respect of the Incentive-Based Compensation, and any gain realized by the Covered Executive upon the subsequent disposition of any property received in connection with any Incentive-Based Compensation); provided, that (i) the amount of Erroneously Awarded Compensation must be computed without regard to any taxes paid by such Covered Executive; and (ii) for Incentive-Based Compensation Received by a Covered Executive based on stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the Accounting Restatement, (A) the amount of Erroneously Awarded Compensation must be based on a reasonable estimate of the effect of the Accounting Restatement on the stock price or total shareholder return upon which the Incentive-Based Compensation was Received, and (B) the Company must maintain documentation of the determination of that reasonable estimate and provide such documentation to the Stock Exchange.

o.Exchange Act” means the Securities Exchange Act of 1934, as amended.

p.“Financial Reporting Measures” means any measures that are determined and presented in accordance with the accounting principles used in the Company’s financial statements, and any measures that are derived wholly or in part from such measures. Stock price and total shareholder return are also Financial Reporting Measures. A Financial Reporting Measure need not be presented within the Company’s financial statements or included in a filing with the SEC to be considered a Financial Reporting Measure.

q.“Incentive-Based Compensation” means any compensation that is granted, earned, or vested based wholly or in part upon the attainment of a Financial Reporting Measure.

r.“little R” Restatement” means an accounting restatement by the Company due to the Company’s material noncompliance with any financial reporting requirement under the securities laws, including any required restatement to correct an error in the Company’s previously issued financial statements that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (i.e., a “little r” restatement).

s.“Policy” means this Amended & Restated Clawback Policy, as it may be amended, restated, supplemented, or otherwise modified from time to time.



t.“Received” means, (i) with respect to Incentive-Based Compensation, actual or deemed receipt of such compensation, and Incentive-Based Compensation will be deemed Received by a Covered Executive in the Company’s fiscal period during which the Financial Reporting Measure specified in the Incentive-Based Compensation award is attained, even if the payment or grant of such Incentive-Based Compensation occurs after the end of that period; and (ii) with respect to Additional Compensation, Additional Compensation that was granted to, vested and/or earned or received by a Covered Executive during the relevant period. For the avoidance of doubt, Incentive-Based Compensation or Additional Compensation that is subject to deferral pursuant to a deferred compensation plan of the Company Group will be deemed Received by the Covered Executive for purposes of this Policy as of the date of deferral.

u.“SEC” means that U.S. Securities and Exchange Commission.

v.“Stock Exchange” means The Nasdaq Stock Market.

3.Administration. This Policy will be administered by the Board or, if so designated by the Board, the Committee, in which case references herein to the Board will be deemed references to the Committee. The Board has full and final authority to make all determinations under this Policy and in compliance with (or pursuant to an exemption from the application of) Section 409A of the Code. The Board may consult with the Audit Committee of the Board in evaluating any determinations made pursuant to this Policy. Any determinations made by the Board will be final, conclusive, and binding on all persons, including the Company, its shareholders, and the Covered Executives. Any action or inaction by the Board with respect to a Covered Executive under this Policy in no way limits the Board’s actions or decisions not to act or to act in a different manner with respect to any other Covered Executive under this Policy or under any similar policy, agreement, or arrangement, nor will any such action or inaction serve as a waiver of any rights that the Company Group may have against any Covered Executive, other than as set forth in this Policy. The Board may authorize and empower any officer or employee of the Company Group to take any and all actions necessary or appropriate to carry out the purpose and intent of this Policy, other than with respect to any recovery under this Policy involving such officer or employee.

4.Scope of Application. This Policy applies to Incentive-Based Compensation and, as applicable, Additional Compensation Received by a Covered Executive on or after the Effective Date and during any applicable Clawback Period if (a) such Incentive-Based Compensation or Additional Compensation was Received by the Covered Executive after beginning service as a Covered Executive, (b) the Covered Executive served as a Covered Executive at any time during the performance period for such Incentive-Based Compensation or Additional Compensation, and (c) the Incentive-Based Compensation or Additional Compensation was Received by the Covered Executive while the Company had a class of securities listed on a national securities exchange or a national securities association.

5.Clawback Requirement. If the Company is required to prepare an Accounting Restatement, the Company Group must recover (and each Covered Executive must repay), reasonably promptly, each Covered Executive’s Erroneously Awarded Compensation, except as provided in Section 9 of this Policy. The Company may recover Erroneously Awarded Compensation in any manner set forth in Section 7 of this Policy.

6.Discretionary Clawback of Additional Compensation. If the Company is required to prepare a “Big R” Restatement, the Board will have the discretion to recover (and, if so determined by the Board, each Covered Executive must repay) any Additional Compensation (to the extent such Additional Compensation is not required to be recovered under Section 5 hereof). The Board will have discretion as to the amount of the Additional Compensation to be recovered and manner, method and timing of recovery. In determining whether to seek recovery of Additional Compensation, and if so, the amount and form of such recovery, the Board may make determinations that are not uniform among the Covered Executives, apply provisions of this Policy differently to each Covered Executive and take into account such considerations as it deems appropriate, including without limitation: (i) the likelihood of success in seeking reimbursement or



forfeiture under governing law versus the cost and effort involved; (ii) whether the assertion of a claim may prejudice the interests of the Company, including without limitation in any related proceeding or investigation; (iii) the passage of time since the occurrence of the act or omission giving rise, directly or indirectly, to the financial restatement; (iv) whether or not the Covered Executive from whom recovery is being sought engaged in fraud or willful misconduct that caused or partially caused the restatement; and/or (v) such other factors as it deems appropriate under the circumstances.

7.Clawback Methods for Incentive Compensation. The Board will determine, in its sole discretion, the timing and method for recovering each Covered Executive’s Erroneously Awarded Compensation in a reasonably prompt manner, which may include, without limitation, one or more of the following methods (applied individually or jointly):

a.requiring the Covered Executive to repay the Company Group in cash or other property determined to be acceptable by the Board;

b.offsetting the Erroneously Awarded Compensation against any compensation otherwise owing by the Company Group to the Covered Executive or to be earned by the Covered Executive;

c.cancelling outstanding vested or unvested cash or equity awards; and

d.taking any other remedial and recovery action authorized by law or contract.

8.Recoupment of Expenses. If the Board determines that a Covered Executive has not complied with the terms of this Policy and reasonably promptly repaid the Covered Executive’s Erroneously Awarded Compensation or Additional Compensation, if required, in full pursuant to the recovery method elected by the Board, the Board will be permitted to, in its discretion, require the Covered Executive (in addition to repaying such amounts to the Company Group) to reimburse the Company Group for any and all expenses reasonably incurred (including reasonable legal fees) by the Company Group in recovering such Erroneously Awarded Compensation or Additional Compensation in accordance with this Policy.

9.Exceptions to Clawback Requirement. Notwithstanding anything to the contrary in this Policy, the Company Group’s recovery obligation under this Policy with respect to a Covered Executive’s Erroneously Awarded Compensation will not apply to the extent that either the Committee or, if the determination is made by the Board, a majority of the independent directors serving on the Board, determines that such recovery would be impracticable and that one or more of the following applies:
a.the direct expense paid to a third party to assist in enforcing this Policy would exceed the amount of the Erroneously Awarded Compensation; provided, that before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on expense of enforcement, the Company Group must (i) make a reasonable attempt to recover such Erroneously Awarded Compensation, (ii) document such reasonable attempt to recover, and (iii) provide that documentation to the Stock Exchange;

b.recovery would violate home country law where that law was adopted prior to November 28, 2022; provided, that before concluding that it would be impracticable to recover any amount of Erroneously Awarded Compensation based on violation of home country law, the Company Group must (i) obtain an opinion of home country counsel, acceptable to the Stock Exchange, that recovery would result in such a violation and (ii) provide such opinion to the Stock Exchange; or

c.recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company Group, to fail to meet the requirements of Section 401(a)(13) of the Code or Section 411(a) of the Code.

10.Indemnification. Notwithstanding the terms of any indemnification arrangement or insurance policy or contract with, or for the benefit of, any Covered Executive, the Company Group may not indemnify any



Covered Executive against the loss of Erroneously Awarded Compensation, including any payment or reimbursement for the cost of third-party insurance purchased by any Covered Executive to fund potential clawback obligations under this Policy, or against the requirement to reimburse the Company hereunder for expenses incurred by the Company in recovering Erroneously Awarded Compensation. No member of the Board who assists in the administration of this Policy will be liable for any action, determination, or interpretation made with respect to this Policy, and each member of the Board will be fully indemnified by the Company Group to the fullest extent under applicable law or Company Group policy with respect to such action, determination, or interpretation.

11.Acknowledgement. Each Covered Executive will be asked to sign and return to the Company an acknowledgement of the application of this Policy, in a form to be provided by the Company; provided, however, the Company may recoup Incentive Compensation or, if applicable, Additional Compensation from each Covered Executive as provided herein, regardless of whether such Covered Executive received from the Company notice, or provided to the Company written acknowledgement, of this Policy.

12.Required Disclosures. The Company will file all disclosures with respect to this Policy in accordance with the requirements of the federal securities laws, including any disclosures required by the SEC.

13.Adoption Date; Effective Date. This Policy was adopted by the Board on October 18, 2023, and will be effective as the Effective Date. This Policy amends and restates in its entirety the Clawback Policy of the Company in place prior to the Effective Date (the “Prior Policy”). The terms and conditions of this Policy will apply to Incentive-Based Compensation or, if applicable, Additional Compensation, that is Received by any Covered Executive on or after the Effective Date, even if such Incentive-Based Compensation or Additional Compensation was approved, awarded, or granted to the Covered Executive prior to the Effective Date. The Prior Policy will continue to apply with respect to Incentive-Based Compensation, or, if applicable, Additional Compensation Received prior to the Effective Date.

14.Amendment; Termination. The Board may amend this Policy from time to time in its discretion. The Board may suspend, discontinue, or terminate this Policy at any time. Notwithstanding anything in this Section 14 to the contrary, no amendment, suspension, discontinuation or termination of this Policy shall be effective if such amendment, suspension, discontinuation or termination would (after taking into account any actions taken by the Company contemporaneously with such amendment, suspension, discontinuation or termination) cause the Company to violate any federal securities laws, SEC rule or Stock Exchange rule.

15.Other Recovery Rights. The Board intends that this Policy will be applied to the fullest permissible extent. The Board may require that any employment agreement, equity award agreement, or similar agreement entered into on or after the Effective Date will, as a condition to the grant of any benefit thereunder, require a Covered Executive to agree to be subject to and to abide by the terms of this Policy. Any right of recovery under this Policy is in addition to, and not in lieu of, any other remedies or rights of recovery that may be available to the Company Group pursuant to the terms of any similar policy in any employment agreement, equity award agreement, or similar agreement and any other legal remedies available to the Company Group. To the extent that the application of this Policy would provide for recovery of Incentive-Based Compensation that the Company Group recovers from a Covered Executive pursuant to Section 304 of the Sarbanes-Oxley Act of 2002 or other recovery obligations, the amount such Covered Executive has already reimbursed the Company Group will be credited to the required recovery under this Policy.

16.Successors. This Policy will be binding and enforceable against all Covered Executives and their beneficiaries, heirs, executors, administrators, and other legal representatives.

17.Governing Law; Venue. This Policy and all rights and obligations hereunder are governed by and construed in accordance with the laws of the State of Delaware, excluding any choice of law rules or principles that may direct the application of the laws of another jurisdiction. All actions arising out of or relating to this Policy will be heard and determined exclusively in the Court of Chancery of the State of Delaware or, if such court declines to exercise jurisdiction or if subject matter jurisdiction over the matter



that is the subject of any such legal action or proceeding is vested exclusively in the U.S. federal courts, the U.S. District Court for the District of Delaware. In the event of any inconsistency between the Policy and the terms of any employment agreement to which a Covered Executive is a party, or the terms of any compensation plan, program, agreement, or arrangement under which any compensation has been granted, awarded, earned, or paid to the Covered Executive, the terms of this Policy will govern.


/s/ Brian P. McKeon
February 22, 2024Brian P. McKeon
Executive Vice President, Chief Financial Officer
and Treasurer


A signed original of this written statement required by Section 906, has been provided to IDEXX Laboratories, Inc. and will be retained by IDEXX Laboratories, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.



Dates Referenced Herein

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/22/24None on these Dates
For Period end:12/31/23
10/18/23
10/2/23
11/28/22
 List all Filings 


30 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/01/23  IDEXX Laboratories, Inc.          10-Q        9/30/23  102:9.6M
10/21/22  IDEXX Laboratories, Inc.          8-K:1,2,9  10/20/22   11:1.3M                                   Donnelley … Solutions/FA
 7/15/22  IDEXX Laboratories, Inc.          8-K:5,9     7/13/22   12:558K
 5/04/22  IDEXX Laboratories, Inc.          10-Q        3/31/22  100:8.3M
 2/16/22  IDEXX Laboratories, Inc.          10-K       12/31/21  151:18M
12/09/21  IDEXX Laboratories, Inc.          8-K:1,2,9  12/09/21   11:1.2M                                   Donnelley … Solutions/FA
11/02/21  IDEXX Laboratories, Inc.          10-Q        9/30/21   98:9.8M
 5/04/21  IDEXX Laboratories, Inc.          10-Q        3/31/21   94:7.7M
 2/12/21  IDEXX Laboratories, Inc.          10-K       12/31/20  131:15M
10/29/20  IDEXX Laboratories, Inc.          10-Q        9/30/20   98:10M
 4/30/20  IDEXX Laboratories, Inc.          10-Q        3/31/20  101:9.4M
 4/16/20  IDEXX Laboratories, Inc.          8-K:1,2,9   4/10/20   15:2.2M                                   ActiveDisclosure/FA
 3/27/20  IDEXX Laboratories, Inc.          8-K:1,2,9   3/23/20   11:294K                                   ActiveDisclosure/FA
 2/14/20  IDEXX Laboratories, Inc.          10-K       12/31/19  139:18M
10/24/19  IDEXX Laboratories, Inc.          8-K:5,7,9  10/23/19   14:662K                                   Toppan Merrill/FA
 3/15/19  IDEXX Laboratories, Inc.          8-K:1,2,9   3/14/19    3:1.3M
 2/15/19  IDEXX Laboratories, Inc.          10-K       12/31/18  139:17M
 3/29/18  IDEXX Laboratories, Inc.          DEF 14A     5/09/18    1:3M                                     DG3/FA
 2/16/18  IDEXX Laboratories, Inc.          10-K       12/31/17  135:20M
 2/17/16  IDEXX Laboratories, Inc.          10-K       12/31/15  120:19M
 6/24/15  IDEXX Laboratories, Inc.          8-K:1,2,9   6/18/15    2:793K                                   Donnelley … Solutions/FA
 7/25/14  IDEXX Laboratories, Inc.          8-K:1,2,9   7/21/14    3:1M                                     Donnelley … Solutions/FA
12/30/13  IDEXX Laboratories, Inc.          S-8        12/30/13    4:134K                                   Donnelley … Solutions/FA
12/12/13  IDEXX Laboratories, Inc.          8-K:1,2,9  12/11/13    2:404K                                   Donnelley … Solutions/FA
 7/23/13  IDEXX Laboratories, Inc.          10-Q        6/30/13  140:15M
 7/23/10  IDEXX Laboratories, Inc.          10-Q        6/30/10   38:5.6M                                   Toppan Merrill/FA
 2/19/10  IDEXX Laboratories, Inc.          10-K       12/31/09    9:1.2M                                   Donnelley … Solutions/FA
 2/27/08  IDEXX Laboratories, Inc.          10-K       12/31/07   14:1.2M                                   Bowne - BPC/FA
 8/03/06  IDEXX Laboratories, Inc.          10-Q        6/30/06    7:1.5M
11/14/02  IDEXX Laboratories, Inc.          10-Q        9/30/02    2:225K
Top
Filing Submission 0000874716-24-000057   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:57:42.3pm ET